title: Refractory angiosarcoma of the breast with VEGFR2 upregulation successfully treated with sunitinib.
authors: Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska.
authors: Edibaldo
authors: E
authors: Silva
authors: Zoran
authors: Z
authors: Gatalica
authors: Semir
authors: S
authors: Vranic
authors: Gargi
authors: G
authors: Basu
authors: Sandeep K
authors: SK
authors: Reddy
authors: Andreas
authors: A
authors: Voss
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology*; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D012189:Retrospective Studies; D000077210:Sunitinib; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000235:genetics*
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; C000588866:KDR protein, human; D040301:Vascular Endothelial Growth Factor Receptor-2; D000077210:Sunitinib